How do I subscribe to ongoing alerts?

Subscribe to /feed/company/centro-de-educaci-n-medica-e-investigaciones-cl-nicas-norberto-quirno.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno pipeline: 1 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
High-Dose Dexamethasone	High-Dose Dexamethasone	marketed	Glucocorticoid (corticosteroid)	Glucocorticoid receptor (GR)	Immunology, Rheumatology, Endocrinology
COVID19 convalescent plasma infusion	COVID19 convalescent plasma infusion	phase 3	Passive immunotherapy / Convalescent plasma		Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1
Immunology, Rheumatology, Endocrinology · 1
Vaccines · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Merck Sharp & Dohme LLC · 2 shared drug classes
University Health Network, Toronto · 2 shared drug classes
Sanofi · 2 shared drug classes
Bharat Biotech International Limited · 1 shared drug class
CanSino Biologics Inc. · 1 shared drug class
Cancer Trials Ireland · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Centre for Infectious Disease Research in Zambia · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno:

Cite this brief

Drug Landscape (2026). Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/centro-de-educaci-n-medica-e-investigaciones-cl-nicas-norberto-quirno. Accessed 2026-05-18.